Carl J Pepine Selected Research

Obesity

9/2013	Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.
10/2007	Obesity paradox in patients with hypertension and coronary artery disease.
9/2004	Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl J Pepine Research Topics

Disease

85	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 05/2002
73	Hypertension (High Blood Pressure) 12/2023 - 02/2003
64	Myocardial Infarction 04/2024 - 08/2002
58	Ischemia 04/2024 - 06/2002
46	Heart Failure 04/2024 - 04/2003
41	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 10/2007
39	Stroke (Strokes) 04/2024 - 02/2004
26	Myocardial Ischemia (Ischemic Heart Diseases) 04/2024 - 08/2002
14	Inflammation (Inflammations) 12/2023 - 02/2004
12	Chest Pain (Chest Pains) 04/2020 - 06/2002
11	Atherosclerosis 03/2024 - 02/2003
8	Hemorrhage 11/2023 - 10/2003
8	Cardiomyopathies (Cardiomyopathy) 01/2023 - 01/2016
8	Coronary Disease (Coronary Heart Disease) 01/2022 - 09/2009
8	Dyslipidemias (Dyslipidemia) 01/2020 - 02/2004
8	Acute Coronary Syndrome 11/2016 - 02/2003
7	ST Elevation Myocardial Infarction 01/2018 - 02/2003
6	Left Ventricular Dysfunction 01/2021 - 02/2010
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2023 - 02/2004
5	COVID-19 05/2023 - 01/2020
5	Infarction (Infarctions) 01/2021 - 05/2002
4	Pathologic Constriction (Stenosis) 03/2024 - 08/2006
4	Stable Angina 10/2022 - 02/2003
4	Diabetes Mellitus 10/2021 - 10/2006
4	Cicatrix (Scar) 01/2021 - 11/2012
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 10/2004
3	Coronary Stenosis (Coronary Artery Stenosis) 12/2023 - 06/2002
3	Neuroinflammatory Diseases 12/2023 - 01/2019
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2018
3	Thrombosis (Thrombus) 11/2021 - 01/2010
3	Rupture 11/2020 - 02/2003
3	Atherosclerotic Plaque (Atheroma) 11/2020 - 02/2004
3	Angina Pectoris 08/2019 - 08/2008
3	Transient Ischemic Attack 02/2015 - 10/2006
3	Unstable Angina 02/2015 - 08/2002
3	Obesity 09/2013 - 09/2004
2	Chronic Renal Insufficiency 10/2023 - 01/2023
2	Dysbiosis 01/2023 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 01/2021
2	Edema (Dropsy) 01/2022 - 02/2003
2	Myocarditis (Carditis) 01/2022 - 03/2021
2	Anemia 01/2022 - 10/2021

Drug/Important Bio-Agent (IBA)

43	Verapamil (Calan)FDA LinkGeneric 01/2021 - 10/2004
40	trandolapril (Mavik)FDA LinkGeneric 01/2021 - 12/2003
28	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 12/2003
23	omega-Chloroacetophenone (Mace)IBA 04/2024 - 06/2012
21	Atenolol (Tenormin)FDA LinkGeneric 01/2016 - 01/2004
16	Adenosine (Adenocard)FDA LinkGeneric 04/2024 - 04/2003
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 02/2004
11	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2023 - 01/2007
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2009
10	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 10/2005
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 12/2002
9	Hormones (Hormone)IBA 01/2018 - 12/2002
8	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 08/2014 - 12/2003
7	LipidsIBA 01/2022 - 06/2002
7	CalciumIBA 11/2021 - 12/2003
6	HDL CholesterolIBA 04/2024 - 02/2004
6	Estrogens (Estrogen)FDA Link 01/2019 - 09/2004
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2005
5	Minocycline (Cyclops)FDA LinkGeneric 12/2023 - 06/2015
5	Angiotensin Receptor AntagonistsIBA 01/2023 - 10/2005
5	CreatinineIBA 10/2021 - 06/2002
5	DiureticsIBA 05/2021 - 08/2008
5	Ranolazine FDA Link 01/2021 - 01/2004
5	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2020 - 01/2004
5	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020 - 02/2004
5	Triglycerides (Triacylglycerol)IBA 12/2017 - 06/2006
5	C-Reactive ProteinIBA 01/2017 - 02/2004
4	Phenobarbital (Luminal)FDA Link 03/2024 - 08/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 12/2015
4	CholesterolIBA 09/2013 - 12/2002
4	LDL CholesterolIBA 03/2011 - 06/2006
4	fenofibric acid FDA Link 03/2011 - 01/2009
3	AnthracyclinesIBA 01/2023 - 01/2018
3	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2023 - 01/2021
3	Mineralocorticoid Receptor AntagonistsIBA 10/2022 - 01/2021
3	Vasodilator Agents (Vasodilators)IBA 01/2022 - 02/2003
3	Hemoglobins (Hemoglobin)IBA 10/2021 - 06/2004
3	Interleukin-6 (Interleukin 6)IBA 08/2021 - 05/2009
3	Angiotensin-Converting Enzyme 2IBA 01/2021 - 10/2013
3	Phytoestrogens (Phytoestrogen)IBA 01/2021 - 06/2006
3	ThiazidesIBA 01/2021 - 01/2020
3	GenisteinIBA 01/2021 - 06/2006
3	Angiotensin IIIBA 01/2019 - 01/2010
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017 - 02/2004
3	EnzymesIBA 08/2011 - 02/2003
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 05/2007 - 02/2006
2	Indicators and Reagents (Reagents)IBA 12/2023 - 02/2004
2	Butyrates (Butyrate)IBA 01/2023 - 01/2021
2	Immunoglobulin A (IgA)IBA 01/2023 - 01/2022
2	1,4-dihydropyridine (dihydropyridine)IBA 01/2022 - 10/2005
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 01/2022

Therapy/Procedure

67	Therapeutics 03/2024 - 05/2002
24	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2023 - 01/2010
8	Drug Therapy (Chemotherapy) 11/2023 - 11/2004
8	Percutaneous Coronary Intervention 12/2019 - 10/2003
4	Secondary Prevention 11/2023 - 01/2010
3	Injections 10/2016 - 04/2012
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2004 - 05/2002